A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome
Clinical trial NCT00001123 · COMPLETED
Trial details
- NCT number
- NCT00001123
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.